In vitro synergistic activity of NCL195 in combination with colistin against Gram-negative bacterial pathogens

Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates

(2021) Julalak C. Ontong et al.   PLoS One

A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens

(2020) Meirong Song et al.   Nature Microbiology

In vitro Activity of Robenidine Analog NCL195 in Combination With Outer Membrane Permeabilizers Against Gram-Negative Bacterial Pathogens and Impact on Systemic Gram-Positive Bacterial Infection in Mice

(2020) Hongfei Pi et al.   Frontiers in Microbiology

The Infectious Diseases Society of America’s 10 × ’20 Initiative (Ten New Systemic Antibacterial Agents FDA-approved by 2020): Is 20 × ’20 a Possibility?

(2019) George H Talbot et al.   CLINICAL INFECTIOUS DISEASES

The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program

(2019) Daniel J. Diekema et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Developments on antibiotics for multidrug resistant bacterial Gram-negative infections

(2019) Georgios L. Voulgaris et al.   Expert Review of Anti-Infective Therapy

In vitro Antimicrobial Activity of Robenidine, Ethylenediaminetetraacetic Acid and Polymyxin B Nonapeptide Against Important Human and Veterinary Pathogens

(2019) Manouchehr Khazandi et al.   Frontiers in Microbiology

Modern clinician-initiated clinical trials to determine optimal therapy for multi-drug resistant Gram-negative infections

(2019) Adam G Stewart et al.   CLINICAL INFECTIOUS DISEASES

Synergistic Activity of Colistin-Containing Combinations against Colistin-Resistant Enterobacteriaceae

(2018) Thea Brennan-Krohn et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antibiotic–non-antibiotic combinations for combating extremely drug-resistant Gram-negative ‘superbugs’

(2017) Elena K. Schneider et al.   Essays in Biochemistry

Intrinsic, adaptive and acquired antimicrobial resistance in Gram-negative bacteria

(2017) Mohsen Arzanlou et al.   Essays in Biochemistry

The drug-resistant bacteria that pose the greatest health threats

(2017) Cassandra Willyard   NATURE

Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent

(2017) Abiodun D. Ogunniyi et al.   PLoS One

Treatment of Gram-negative bacterial infections by potentiation of antibiotics

(2016) Thomas P Zabawa et al.   CURRENT OPINION IN MICROBIOLOGY

Molecular mechanisms of polymyxin resistance: knowns and unknowns

(2016) Sophie Baron et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Synergistic combinations of polymyxins

(2016) Justin R. Lenhard et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Robenidine Analogues as Gram-Positive Antibacterial Agents

(2016) Rebecca J. Abraham et al.   JOURNAL OF MEDICINAL CHEMISTRY

Polymyxin Combinations: Pharmacokinetics and Pharmacodynamics for Rationale Use

(2015) Phillip J. Bergen et al.   PHARMACOTHERAPY

Is transmission electron microscopy (TEM) a promising approach for qualitative and quantitative investigations of polymyxin B and miconazole interactions with cellular and subcellular structures of Staphylococcus pseudintermedius , Escherichia coli , Pseudomonas aeruginosa and Malassezia pachydermatis ?

(2015) Michael Voget et al.   VETERINARY MICROBIOLOGY

Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It

(2015) Helen I. Zgurskaya et al.   ACS Infectious Diseases

Approval and Withdrawal of New Antibiotics and other Antiinfectives in the U.S., 1980–2009

(2015) Kevin Outterson et al.   JOURNAL OF LAW MEDICINE & ETHICS

Antimicrobial mechanism of flavonoids against Escherichia coli ATCC 25922 by model membrane study

(2014) Mengying He et al.   APPLIED SURFACE SCIENCE

Adverse Reactions Associated with Systemic Polymyxin Therapy

(2014) Julie Ann Justo et al.   PHARMACOTHERAPY

Synergistic Effect between Colistin and Bacteriocins in Controlling Gram-Negative Pathogens and Their Potential To Reduce Antibiotic Toxicity in Mammalian Epithelial Cells

(2013) Karim Naghmouchi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens

(2013) L. Phee et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Clinical relevance of the ESKAPE pathogens

(2013) Jack N Pendleton et al.   Expert Review of Anti-Infective Therapy

The Target of Daptomycin Is Absent from Escherichia coli and Other Gram-Negative Pathogens

(2012) Christopher P. Randall et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Evaluation of Antibiotic Synergy for Polymyxin B-Resistant Carbapenemase-Producing Klebsiella pneumoniae

(2010) A. Elemam et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement

(2008) Ian Chopra et al.   LANCET INFECTIOUS DISEASES